During the past decade, Yodogawa Christian Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yodogawa Christian Hospital" #1 sponsor was "Shire" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Neonatal Encephalopathy Consortium, Japan" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yodogawa Christian Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Kurashiki Central Hospital" with 2 trials as a collaborator, "Nagoya University" with 2 trials as a collaborator, "National Center for Child Health and Development, Japan" with 2 trials as a collaborator and "National Cerebral and Cardiovascular Center" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Yodogawa Christian Hospital" are "Crohn's Disease" (3 trials), "Heart Failure" (3 trials), "Ulcerative Colitis" (3 trials), "Anemia" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Yodogawa Christian Hospital" in a lesser frequency.

Most popular intervention types in "Yodogawa Christian Hospital" are "Drug" (9 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ontamalimab" (4 trials), "Empagliflozin" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yodogawa Christian Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Yodogawa Christian Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Yodogawa Christian Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Yodogawa Christian Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".